Evidence mapPaperPMID 41258301Full record

ArticleNPJ systems biology and applications2025

Path-based quantification of activation and repression in Boolean models using BooLEVARD.

Marco Fariñas, Eirini Tsirvouli, John Zobolas, Tero Aittokallio, Åsmund Flobak, Kaisa Lehti

Abstract read
In one paragraph

Article in NPJ systems biology and applications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marco FariñasDepartment of Biomedical Laboratory Science, Norwegian University of Science and Technology (NTNU), Trondheim, Norway. marco.farinas@ntnu.no.
Eirini TsirvouliDepartment of Biology, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
John ZobolasDepartment of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital (OUH), Oslo, Norway.
Tero AittokallioDepartment of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital (OUH), Oslo, Norway.
Åsmund FlobakDepartment of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
Kaisa LehtiDepartment of Biomedical Laboratory Science, Norwegian University of Science and Technology (NTNU), Trondheim, Norway. kaisa.lehti@ntnu.no.

Funding

ERA PerMed 329059Norwegian Cancer Society 216104Norwegian Cancer Society 216113Novo Nordisk Foundation NNF21OC0070381South-Eastern Norway Regional Health Authority 2020026Swedish Cancer Society 211888The Research Council of Norway 310160
6 · The paper itself

Abstract

Boolean models are a powerful resource for studying dynamic processes of biological systems. However, their inherent discrete nature limits their ability to capture continuous aspects of signal transduction, such as signal strength or protein activation levels. Although existing tools provide some path exploration capabilities that can be used to explore signal transduction circuits, the computational workload often requires simplifying assumptions that compromise the accuracy of the analysis. Here, we introduce BooLEVARD, a Python package designed to efficiently quantify the number of paths leading either to node activation or repression in Boolean models, which offers a more detailed and quantitative perspective on how molecular signals propagate through signaling networks. By focusing on the collection of non-redundant paths directly influencing Boolean outcomes, BooLEVARD enhances the precision of signal strength representation. We showcase the application of BooLEVARD in studying cell-fate decisions using a Boolean model of cancer metastasis, demonstrating its ability to identify critical signaling events. In addition, through a second use case, we demonstrated BooLEVARD's capability to scale efficiently across increasingly large and connected Boolean models. Through these properties, BooLEVARD provides a distinctive tool for quantitative analysis of signaling dynamics within Boolean models, which can increase our understanding of disease development and drug responses. BooLEVARD is freely available at https://github.com/farinasm/boolevard .

Indexed as

Computational BiologyModels, BiologicalSoftwareAlgorithmsComputer SimulationHumansSignal Transduction

Identifiers

PMID41258301
PMCPMC12630683

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.